Skip to content

Role of Varunadi Churn in the management of Kidney Stone

Pharmacognostical & clinical study of Varunadi Churn (Kalpit Yog) in the Management of Ashmari w.s.r To Renal Calculus - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027673
Enrollment
40
Registered
2020-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Varunadi Churn: Two Dose Of 5gms With Water Before Meal For 15 Days Control Intervention1: Neeri tablet: two tab with water twice a day before meal for 15 days Control Intervention2: NE

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Both male and female patients of age between 15 to 60 years. 2.Patients presenting with the symptoms of ASHMARI roga. Eg â?? Burning micturition, Hematuria. 3.Renal calculi size 20 mm. 4.Pain in in the renal angle and loin region, radiating towards groin. 5.Radiographic / USG evidence of the stone. 6.Crystals of stone in urine.

Exclusion criteria

Exclusion criteria: 1. Patient below 15 yrs. and above 60 yrs 2. Patient suffering from renal disorder other than renal calculus. 3. Pregnant women. 4. Renal failure. 5. Case of immediate surgical intervention. 6. Severe hematuria. 7. Stone size more than 20 mm. 8. Patients of carcinoma, Tuberculosis, HIV positive, VDRL positive. Hepatitis-B positive 9. Patient suffering from cardiac, Asthma, Pulmonary diseases. 10. Eosinophilia, Emphysema, Chronic bronchitis, Bronchiectasis etc. 11. Patients having major illness, IDDM, DM which is poorly controlled.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parametersTimepoint: 21 days

Secondary

MeasureTime frame
To Compare The Efficacy Of Treatments In Both GroupsTimepoint: 21 Days

Countries

India

Contacts

Public ContactDr Shail Bala Mehar

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

chandan_singh4@yahoo.com9950156020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026